Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosome quality control complex subunit TCF25 (TCF25) is a protein component of the ribosome-associated quality control (RQC) pathway that ensures the proteasomal degradation of nascent polypeptides arising from stalled translation events[5][1][2]. TCF25 works within the RQC complex alongside LTN1 and NEMF, where it specifically promotes the formation of Lys-48-linked (K48) ubiquitin chains on incomplete translation products, marking them for rapid degradation by the proteasome[1][5]. TCF25 also acts as a transcriptional repressor and is structurally characterized by a basic helix-loop-helix motif; it was originally described as a transcription factor (NULP1), but its major known biological role is currently in ribosome quality control[2][6]. Disruption of TCF25 or the RQC complex can lead to defects in proteostasis and is linked with adverse effects, particularly in neuronal tissue, but compensatory mechanisms exist to maintain cell viability when RQC function is compromised[2]. There are no known drugs or therapeutic interventions that directly target TCF25, nor is it widely considered a therapeutic target at present.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosome quality control complex subunit TCF25 (TCF25).